126 related articles for article (PubMed ID: 26506882)
1. Clinical and prognostic analysis in 32 pediatric nasopharyngeal carcinoma.
Chen J; Hu F
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C226-9. PubMed ID: 26506882
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma.
Chen J; Liu T; Sun Q; Hu F
Medicine (Baltimore); 2018 Dec; 97(49):e13483. PubMed ID: 30544441
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
Cao KJ; Li Y; Xie GF; Hong MH
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020
[TBL] [Abstract][Full Text] [Related]
4. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
Liu K; Han Y; Ma B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with nasopharyngeal carcinoma treated in Hospital Kuala Lumpur.
El-Sherbieny E; Rashwan H; Lubis SH; Choi VJ
Asian Pac J Cancer Prev; 2011; 12(7):1739-43. PubMed ID: 22126556
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients.
Liu W; Tang Y; Gao L; Huang X; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G; Yi J
Radiat Oncol; 2014 Dec; 9():274. PubMed ID: 25477058
[TBL] [Abstract][Full Text] [Related]
7. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
[TBL] [Abstract][Full Text] [Related]
8. With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.
Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Chen MY; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
BMC Cancer; 2016 Oct; 16(1):774. PubMed ID: 27717335
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy.
Wang M; Xu Y; Chen X; Chen H; Gong H; Chen S
J Cancer Res Ther; 2016; 12(2):909-14. PubMed ID: 27461673
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
[TBL] [Abstract][Full Text] [Related]
11. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic analysis of nasopharyngeal carcinoma patients with distant metastasis after curative radiotherapy].
Chen J; Zong J; Wu J; Pan J
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):216-21. PubMed ID: 25975793
[TBL] [Abstract][Full Text] [Related]
13. [Multivariate analysis of prognostic makers in patients with nasopharyngeal carcinoma intreatment of radiotherapy combined with induction chemotherapy].
Liu J; Li S; Wang Y; Shi Y; Zhu L; Wu C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):937-40. PubMed ID: 26596014
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
16. The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Peng H; Chen L; Zhang Y; Li WF; Mao YP; Liu X; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
Sci Rep; 2016 Apr; 6():24835. PubMed ID: 27099096
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of grading masticator space involvement in nasopharyngeal carcinoma according to MR imaging findings.
Zhang GY; Huang Y; Cai XY; Chen XP; Xu T; Wu J; Wei WH; Liu LZ; Huang ZL; Zhou MM; Xia ST; Wang YJ
Radiology; 2014 Oct; 273(1):136-43. PubMed ID: 24844470
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
19. Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma.
Fangzheng W; Chuner J; Lei W; Weijun C; Min X; Quanquan S; Tongxin L; Aizawa R; Sakamoto M; Zhenfu F
Oncotarget; 2017 Jun; 8(24):39756-39765. PubMed ID: 28055973
[TBL] [Abstract][Full Text] [Related]
20. Induction Methotrexate, Cisplatin, and 5-Fluorouracil Versus Cisplatin and 5-Fluorouracil Followed by Radiotherapy in Pediatric Nasopharyngeal Carcinoma: A Retrospective Analysis in a Tertiary Cancer Center.
Al Mousa A; Abu-Hijlih R; Salem A; Sultan I; Mula-Hussain L; Ismael T; Mohamad I
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e437-e442. PubMed ID: 28816803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
